KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Prepaid Assets: 2017-2024

Historic Prepaid Assets for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to $3.3 million.

  • Aquestive Therapeutics' Prepaid Assets rose 48.33% to $2.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 million, marking a year-over-year increase of 48.33%. This contributed to the annual value of $3.3 million for FY2024, which is 77.24% up from last year.
  • Per Aquestive Therapeutics' latest filing, its Prepaid Assets stood at $3.3 million for FY2024, which was up 77.24% from $1.9 million recorded in FY2023.
  • Aquestive Therapeutics' Prepaid Assets' 5-year high stood at $3.4 million during FY2020, with a 5-year trough of $1.9 million in FY2023.
  • Moreover, its 3-year median value for Prepaid Assets was $2.1 million (2022), whereas its average is $2.4 million.
  • In the last 5 years, Aquestive Therapeutics' Prepaid Assets plummeted by 30.74% in 2022 and then skyrocketed by 77.24% in 2024.
  • Over the past 5 years, Aquestive Therapeutics' Prepaid Assets (Yearly) stood at $3.4 million in 2020, then fell by 9.55% to $3.1 million in 2021, then crashed by 30.74% to $2.1 million in 2022, then declined by 13.00% to $1.9 million in 2023, then surged by 77.24% to $3.3 million in 2024.